2024
DOI: 10.1038/s41746-024-01015-w
|View full text |Cite
|
Sign up to set email alerts
|

Unraveling cradle-to-grave disease trajectories from multilayer comorbidity networks

Elma Dervić,
Johannes Sorger,
Liuhuaying Yang
et al.

Abstract: We aim to comprehensively identify typical life-spanning trajectories and critical events that impact patients’ hospital utilization and mortality. We use a unique dataset containing 44 million records of almost all inpatient stays from 2003 to 2014 in Austria to investigate disease trajectories. We develop a new, multilayer disease network approach to quantitatively analyze how cooccurrences of two or more diagnoses form and evolve over the life course of patients. Nodes represent diagnoses in age groups of t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 34 publications
0
1
0
Order By: Relevance
“…Giannoula et al [11] suggested a more straightforward approach involving matching diagnosis codes from patients' records and extracting matched diagnosis sequences. Network-based frameworks are also used, identifying the shortest paths between diseases in the network, as shown by Dervić et al [12]. While these methods have advanced our understanding, they often rely on model assumptions that oversimplify complex disease interactions and overlook important intermediate steps and nuances in disease progression.…”
Section: Introductionmentioning
confidence: 99%
“…Giannoula et al [11] suggested a more straightforward approach involving matching diagnosis codes from patients' records and extracting matched diagnosis sequences. Network-based frameworks are also used, identifying the shortest paths between diseases in the network, as shown by Dervić et al [12]. While these methods have advanced our understanding, they often rely on model assumptions that oversimplify complex disease interactions and overlook important intermediate steps and nuances in disease progression.…”
Section: Introductionmentioning
confidence: 99%